Tempest Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tempest Therapeutics generated cash of -$27,357,000, which is more than the previous year. Cash used in financing activities reached the amount of $35,602,000 last year. Net change in cash is therefore $8,075,000.
Cash Flow
| 2014 | -30.58M | -32.78M | 51.71M |
|---|---|---|---|
| 2015 | -50.28M | -38.29M | 125.38M |
| 2016 | -61.73M | 8.29M | 54.14M |
| 2017 | -20.34M | 458K | -4.46M |
| 2018 | -23.64M | 1.93M | 77.74M |
| 2019 | -41.22M | 3.98M | 26.94M |
| 2020 | -19.01M | -6K | 34.59M |
| 2021 | -25.95M | -97K | 59.06M |
| 2022 | -31.07M | -562K | 11.40M |
| 2023 | -27.35M | -170K | 35.60M |
TPST Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 31.59M | 51.82M | 18.82M | 3.24M | 73.33M | 17.62M | 43.93M | 43.22M | 6.41M | 18.07M |
Operating activities | ||||||||||
Net income | -29.49M | -35.70M | -28.30M | -19.20M | -44.56M | -27.19M | -84.57M | -82.26M | -73.21M | -49.52M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 381K | 638K | 374K | 339K | 1.05M | 32K | 28K | 2.23M | 1.28M | 450K |
Stock-based compensation expense | 2.54M | 1.56M | 1.10M | 453K | 310K | 0 | 6.89M | 9.21M | 19.33M | 12.40M |
| Deferred income tax benefit | 2.54M | 1.56M | 1.10M | 453K | 310K | 0 | 6.89M | 9.21M | 19.33M | 12.40M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -263K | 1K | -209K | -574K | -469K | 320K | -1.45M | -1.17M | -171K | 2.31M |
Cash generated by operating activities | -27.35M | -31.07M | -25.95M | -19.01M | -41.22M | -23.64M | -20.34M | -61.73M | -50.28M | -30.58M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -68.85M | -82.67M | -96.72M | -57.60M |
Investments In Property Plant And Equipment | -170K | -562K | -135K | -50K | -397K | -36K | -4K | -2.58M | -5.22M | -2.80M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | -1M | 462K | 0 | 0 | 0 |
Cash generated by investing activities | -170K | -562K | -97K | -6K | 3.98M | 1.93M | 458K | 8.29M | -38.29M | -32.78M |
Financing activities | ||||||||||
Common Stock Issued | 35.60M | 8.86M | 33.42M | 34.59M | 27.14M | 38.75M | 2K | 53.92M | 125.38M | 51.73M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -4.73M | -14.90M | 0 | -202K | -169K | -4.46M | 0 | 0 | 0 |
Cash used in financing activities | 35.60M | 11.40M | 59.06M | 34.59M | 26.94M | 77.74M | -4.46M | 54.14M | 125.38M | 51.71M |
Net Change In Cash | 8.07M | -20.23M | 33.00M | 15.57M | -9.81M | 56.14M | -26.30M | 706K | 37.00M | -11.66M |
Cash at end of period | 39.67M | 31.59M | 51.82M | 18.82M | 63.51M | 73.77M | 17.62M | 43.93M | 43.42M | 6.41M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |